Newcastle University to Use Horizon's X-MAN Models | GenomeWeb

NEW YORK (GenomeWeb news) – Scientists at Newcastle University will study a panel of Horizon Discovery's mutant and normal X-MAN cancer models for imaging biomarkers that can identify cancer genes within tumors, the university said today.

The goal of the research, which is set to begin this month, is to identify markers that will lead to targeted and personalized drug therapies.

Horizon developed the X-MAN models using its Genesis gene engineering technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.